Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden

The European Respiratory Journal
Ilias GalanisBirgitta Henriques-Normark

Abstract

The effects of pneumococcal conjugated vaccines (PCVs) need to be investigated. In Stockholm County, Sweden, PCV7 was introduced in the childhood immunisation programme in 2007 and changed to PCV13 in 2010.Over 90% of all invasive isolates during 2005-2014 (n=2336) and carriage isolates, 260 before and 647 after vaccine introduction, were characterised by serotyping, molecular typing and antibiotic susceptibility, and serotype diversity was calculated. Clinical information was collected for children and adults with invasive pneumococcal disease (IPD).The IPD incidence decreased post-PCV7, but not post-PCV13, in vaccinated children. Beneficial herd effects were seen in older children and adults, but not in the elderly. The herd protection was more pronounced post-PCV7 than post-PCV13. PCV7 serotypes decreased. IPD caused by PCV13 serotypes 3 and 19A increased post-PCV7. Post-PCV13, serotypes 6A and 19A, but not serotype 3, decreased. The serotype distribution changed in carriage and IPD to nonvaccine types, also in nonvaccinated populations. Expansion of non-PCV13 serotypes was largest following PCV13 introduction. Serotype diversity increased and nonvaccine clones emerged, such as CC433 (serotype 22F) in IPD and CC62 (serotype ...Continue Reading

References

Oct 1, 1995·Journal of Clinical Microbiology·J Henrichsen
Aug 19, 2000·The Journal of Infectious Diseases·B HenriquesG Källenius
Dec 7, 2002·The Lancet Infectious Diseases·Uwe KoedelHans-Walter Pfister
May 2, 2003·The New England Journal of Medicine·Cynthia G WhitneyUNKNOWN Active Bacterial Core Surveillance of the Emerging Infections Program Network
Feb 21, 2004·The Journal of Infectious Diseases·A SandgrenB Henriques Normark
Jan 20, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K SjöströmB Henriques-Normark
Mar 15, 2006·PLoS Genetics·Stephen D BentleyBrian G Spratt
Feb 3, 2007·Journal of Clinical Microbiology·In Ho ParkMoon H Nahm
Apr 7, 2007·Science·Keith P Klugman, Shabir A Madhi
Apr 19, 2008·The Journal of Infectious Diseases·Matthew R MooreBernard Beall
Sep 15, 2009·Lancet·Katherine L O'BrienUNKNOWN Hib and Pneumococcal Global Burden of Disease Study Team
Dec 2, 2009·The Journal of Infectious Diseases·Tamara PilishviliUNKNOWN Active Bacterial Core Surveillance/Emerging Infections Program Network
Dec 17, 2009·Vaccine·Jessica Darenberg, Birgitta Henriques Normark
Feb 26, 2010·Nature·Steve PatersonMichael A Brockhurst
Sep 9, 2010·The Journal of Infectious Diseases·Jonathan A McCullersBirgitta Henriques Normark
Feb 14, 2012·The Pediatric Infectious Disease Journal·Sean P FitzwaterHope L Johnson
Oct 19, 2012·The Pediatric Infectious Disease Journal·Katherine DoneganUNKNOWN Collaborative HIV Paediatric Study (CHIPS)
Jul 3, 2013·Cold Spring Harbor Perspectives in Medicine·Birgitta Henriques-Normark, Elaine I Tuomanen
Jul 5, 2013·Journal of Clinical Microbiology·Kwan Soo KoJae-Hoon Song
Nov 13, 2013·Journal of Critical Care·José Manuel PereiraJosé Artur Paiva
Jul 19, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Zitta Barrella HarboePalle Valentiner-Branth

❮ Previous
Next ❯

Citations

Jan 24, 2017·Epidemiology and Infection·A Röckert TjernbergJ F Ludvigsson
Feb 23, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sanjay JayasinghePeter McIntyre
Mar 1, 2018·Physiological Reviews·A P HakanssonD Bogaert
Nov 14, 2017·Expert Review of Vaccines·Michael E Pichichero
Mar 22, 2016·F1000Research·Mathias W PletzSebastian Ott
Oct 13, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nirma Khatri VadlamudiFawziah Marra
Mar 1, 2019·Japanese Journal of Infectious Diseases·Dongchul ParkJeong Hwan Shin
Oct 3, 2017·Biomédica : revista del Instituto Nacional de Salud·Paola Andrea PalaciosJaime Moreno
Jul 4, 2019·Journal of Medical Microbiology·Lucia Gonzales-SilesEdward R B Moore
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pontus NauclerBirgitta Henriques-Normark
Nov 2, 2019·The Journal of Infectious Diseases·Heidi M SoetersChris Van Beneden
Dec 5, 2019·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Weidong MenKaihu Yao
Oct 8, 2019·Expert Review of Vaccines·Myint Tin Tin HtarLuis Jodar
Feb 8, 2020·The Pediatric Infectious Disease Journal·Reshmi Mukerji, David E Briles
Apr 3, 2020·Expert Review of Vaccines·Adriano ArguedasBradford D Gessner
Apr 28, 2018·The Journal of Infectious Diseases·Federico IovinoBirgitta Henriques-Normark
Nov 21, 2019·Indian Journal of Medical Microbiology·Rosemol VargheseS Balasubramanian
Dec 4, 2019·The Journal of Antimicrobial Chemotherapy·Stephanie W LoUNKNOWN Global Pneumococcal Sequencing Consortium
Dec 17, 2016·Emerging Infectious Diseases·Catherine HousemanRussell Gorton
Jul 10, 2018·The Journal of Antimicrobial Chemotherapy·Alyssa R GoldenUNKNOWN Canadian Antimicrobial Resistance Alliance (CARA)

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis

Software Mentioned

epitools
exactci
R

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.